Notice2022-00078
Notice of Award of a Single-Source Cooperative Agreement To Fund the Kinshasa School of Public Health, Democratic Republic of the Congo (KSPH, DRC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 7, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $700,000, with an expected total funding of $3,500,000 over a five-year period, to the Kinshasa School of Public Health, Democratic Republic of the Congo (KSPH DRC). The award will support the investigation of the epidemiological, ecological, and anthropological aspects of monkeypox and assess clinical intervention strategies in the Democratic Republic of Congo (DRC). These activities align with CDC priorities to promote surveillance and global health to prevent the international spread of diseases and to control them at the source.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 5 (Friday, January 7, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 5 (Friday, January 7, 2022)]
[Notices]
[Pages 975-976]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-00078]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Kinshasa School of Public Health, Democratic Republic of the Congo
(KSPH, DRC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $700,000, with an expected total funding of
$3,500,000 over a five-year period, to the Kinshasa School of Public
Health, Democratic Republic of the Congo (KSPH DRC). The award will
support the investigation of the epidemiological, ecological, and
anthropological aspects of monkeypox and assess clinical intervention
strategies in the Democratic Republic of Congo (DRC). These activities
align with CDC priorities to promote surveillance and global health to
prevent the international spread of diseases and to control them at the
source.
DATES: The period for this award will be September 30, 2022, through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Dr. Amy Yang, National Center for HIV,
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention, 1600 Clifton Road NE, MS US8-1, Atlanta, GA
30329-4027, Telephone: 404-718-8835, Email: <a href="/cdn-cgi/l/email-protection#3b5854494b645e494b54640303080e7b585f58155c544d"><span class="__cf_email__" data-cfemail="3a5955484a655f484a55650202090f7a595e59145d554c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This single-source award will support the
investigation of the epidemiological, ecological, and anthropological
aspects of monkeypox and assess clinical intervention strategies in the
DRC. Research activities will focus on improvement and evaluation of
lab-based surveillance systems, investigations of animal reservoirs and
human behaviors at the human-animal interface, epidemiologic
investigations, genome sequencing and phylogenetic analysis, risk
mitigation, enhancing health communication strategies, and clinical
evaluation of vaccines and therapeutic treatments. The research should
provide the DRC Ministry of Health and other key stakeholders with
evidence-based strategies to develop
[[Page 976]]
monkeypox and other zoonotic disease interventions.
The Kinshasa School of Public Health, Democratic Republic of the
Congo (KSPH, DRC) is in a unique position to conduct this work, as it
has a distinct role in the public health system of DRC by being both an
institute of the University of Kinshasa and previously serving as the
bone fide agent of the Ministry of Health; is the implementing partner
for an open label trial of JYNNEOS smallpox vaccine in the healthcare
workers of Tshuapa Province (2017-present), a study that will continue
under the new cooperative agreement; along with their partners at the
University of Kinshasa, has 10 years of experience in conducting
rigorous investigations of potential monkeypox reservoir species; and
has continually maintained a field office in Tshuapa Province devoted
to monkeypox surveillance and research since 2011. This longstanding
commitment to working in this area has yielded the most thorough
longitudinal dataset on monkeypox incidence globally since smallpox
eradication. No other indigenous or foreign institution has been able
to sustain a continual field site for this length of time in a
monkeypox-endemic area of DRC.
Summary of the Award
Recipient: The Kinshasa School of Public Health, Democratic
Republic of the Congo (KSPH, DRC).
Purpose of the Award: The purpose of this award is to investigate
the epidemiological, ecological, and anthropological aspects of
monkeypox and assess clinical intervention strategies in the Democratic
Republic of Congo (DRC). This research may extend to other zoonotic and
vaccine-preventable diseases that are of importance in the DRC and
elsewhere.
Amount of Award: $700,000 in Federal Fiscal Year (FYY) 2022 funds,
and an estimated $700,000 for each subsequent 12-month budget period
over five years, subject to availability of funds.
Authority: This program is authorized under Public Health Service
Act, Sections 301(a) [42 U.S.C. 241(a)] and 307 [42 U.S.C. 242l].
Period of Performance: September 30, 2022, through September 29,
2027.
Dated: January 4, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-00078 Filed 1-6-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 7, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.